#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cryoglobulinaemia Glomerulonephritis chronic Squamous cell carcinoma of the hypopharynx Chordoma Chronic lymphocytic leukaemia refractory Hormone-dependent prostate cancer Metabolic disorder Neoplasm malignant Thromboangiitis obliterans Tourette's disorder Von Willebrand's disease Non-small cell lung cancer metastatic Brain injury Basal cell naevus syndrome Paraganglion neoplasm More trials…

    Learn about Rare Diseases

    Lymphangiosarcoma Haemophilia A with anti factor VIII – Treatment Hereditary ataxia – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Osteosarcoma metastatic – Basic Information Adrenocortical carcinoma – Basic Information Biotinidase deficiency – Treatment Cholangitis sclerosing – Basic Information Vascular malformation – Trials in Disease Mast cell activation syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ranibizumab Tiotropium Bromide Amy109 Aprepitant Brimonidine Ropeginterferon Alfa-2B Gallium (68Ga) Gozetotide Mitoxantrone Hydrochloride Sym024 Cemdisiran Tilsotolimod Sodium METAMIZOLE SODIUM Azd4831 Ucart22 TAZAROTENE Histamine Dihydrochloride Abiraterone Acetate Abacavir Sulfate Phenylephrine Hydrochloride Mirabegron More therapies…

    Learn about Your Condition

    PIK3CA-activated mutation Gastrointestinal melanoma Left ventricular failure Cytomegalovirus infection Myxofibrosarcoma Acute respiratory failure Oesophagogastroscopy Vulvovaginal candidiasis Procedural haemorrhage Arteriospasm coronary Sarcoma Subdural haematoma Type IIa hyperlipidaemia Ventricular tachycardia Neuroendocrine tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2yr Bpgqtdmod Di Sizzwe Miwlzmiugju Bi 1cuq Mlymxofush 1oywot Fygigg

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Atezolizumab, Bevacizumab, and Paclitaxel for Advanced Lung Cancer Patients After Immunotherapy and Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Paclitaxel
    France

  • Study on the Safety and Effectiveness of Sacituzumab Govitecan for Patients with Triple Negative Metastatic Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Sacituzumab Govitecan
    Belgium France

  • Study on Botensilimab Alone and with Balstilimab or Drug Combination for Patients with Refractory Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer metastatic
    Investigated Drugs:
    • Balstilimab
    • Botensilimab
    • Regorafenib
    Belgium France Italy Spain

  • Study on Surgery with or without Darolutamide for Patients with High-Risk or Locally Advanced Prostate Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Darolutamide
    France

  • Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Datopotamab Deruxtecan
    Austria Belgium Czechia France Germany Greece +7

  • Study on Azacitidine and Gilteritinib for Adults with Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gilteritinib
    • Azacitidine
    France

  • Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Darolutamide
    Belgium Bulgaria Czechia Estonia Finland France +11

  • Study on the Safety and Effectiveness of SKB264 and Pembrolizumab for Patients with Cervical, Urothelial, Ovarian, or Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Anhydrous Caffeine
    • Paracetamol Dc
    • Paracetamol Ph. Eur.
    Belgium France Poland Spain

  • Study on Alpelisib and Fulvestrant or Ribociclib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer with PIK3CA Mutations

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Goserelin
    • Leuprorelin
    • Alpelisib
    France

  • Study on the Effectiveness of Ompenaclid with FOLFIRI and Bevacizumab for Patients with Advanced or Metastatic Colorectal Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Rgx-202
    • Bevacizumab
    • Fluorouracil
    Belgium France Spain
Previous Page
1 … 37 38 39 40 41 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!